Showing results (261-270 of 2,886) with videos related to
Sort By:
Pageof 289
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 9, 2019
Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillationNina Huppertz, Gregory Y H Lip, Deirdre A LaneInternational Journal of Clinical Practice|June 10, 2022
Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke PreventionHanis Zulkifly, Gregory Y H Lip, Deirdre A LaneExpert Opinion on Pharmacotherapy|June 15, 2007
Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?J Rumi Jaumdally, Chetan Varma, Gregory Y H LipInternational Journal of Clinical Practice|November 30, 2020
Atrial fibrillation and cardiac arrhythmia associated with acute dental infection: A systematic literature review and case reportAmaar Hassan, Gregory Y H Lip, Rebecca V HarrisExpert Review of Hematology|July 26, 2017
Clinical implications, benefits and pitfalls of using and reversing non-vitamin K antagonist oral anticoagulantsAlexandra Sophie Moss, Gerasimos Dimitropoulous, Gregory Y H LipThe American Journal of Cardiology|August 13, 2017
Bleeding Risk Scores in Atrial Fibrillation and Venous ThromboembolismHanis Zulkifly, Gregory Y H Lip, Deirdre A LaneInternational Journal of Cardiology|May 9, 2016
Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: Observations from the SPORTIF trialsMarco Proietti, Deirdre A Lane, Gregory Y H LipHeart Rhythm|November 29, 2017
Use of the SAMe-TT2R2 score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A reviewHanis Zulkifly, Gregory Y H Lip, Deirdre A LaneAnnals of Medicine|April 3, 2018
Fitting the right non-vitamin K antagonist oral anticoagulant to the right patient with non-valvular atrial fibrillation: an evidence-based choiceYan-Guang Li, Daniele Pastori, Gregory Y H LipExpert Opinion on Pharmacotherapy|August 20, 2010
Stroke prevention in atrial fibrillation patientsRicarda Marinigh, Gregory Y H Lip, Deirdre A LanePageof 289